Skip to main content
Veterinary Medicines

Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg

Authorised
This information is not available for this product.

Product identification

Medicine name:
Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg
Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg
Active substance:
This information is not available for this product.
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 2 tablets.
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 4 tablets.
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 12 blisters, each blister contains 4 tablets (total 48 tablets).

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tad Pharma GmbH
  • Krka d.d. Novo Mesto
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10774/063/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0528/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."